Sign In
Buy NMDBF
$0.0076
+0 (+0%)
At Close: Mar 13, 2023
NeonMind to Present at H.C. Wainwright Bioconnect Conference
04:00am, Thursday, 06'th Jan 2022
VANCOUVER, BC / ACCESSWIRE / January 6, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, announced
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
11:10am, Thursday, 02'nd Dec 2021
VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused
NeonMind to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
07:30am, Thursday, 07'th Oct 2021
VANCOUVER, BC, Oct. 7, 2021 /PRNewswire/ -- NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) ("NeonMind" or the "Company"), based in Vancouver, focused on the potential therapeutic u
NeonMind Advances Strategy for Specialty Clinic Launch
06:00am, Tuesday, 28'th Sep 2021
Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry treatments to underserved popula
Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant Depression VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeonMind Biosciences I
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
06:00am, Thursday, 16'th Sep 2021
Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics VANCOUVER, BC / ACCESSWIRE / September 16, 2021 / NeonMind Bio
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
06:00am, Monday, 13'th Sep 2021
Reflects Strategic Focus on Psychedelic Treatments with Major Milestones in 2021 VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
06:00am, Wednesday, 08'th Sep 2021
VANCOUVER, BC / ACCESSWIRE / September 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind''or the "Company"), an integrated drug development and wellness company focused o
NeonMind Announces DTC Eligibility
06:00am, Wednesday, 25'th Aug 2021
VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
06:00am, Tuesday, 17'th Aug 2021
VANCOUVER, BC / ACCESSWIRE / August 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
06:00am, Thursday, 05'th Aug 2021
Designed to Accelerate Execution of Integrated Drug Development Plan for NEO-001 to Treat Obesity Establishes R&D Advisory Board, Appoints Philippe Martin as Chairman Expands Regulatory Capabilities
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
06:00am, Wednesday, 28'th Jul 2021
VANCOUVER, BC / ACCESSWIRE / July 28, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FFE:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on t
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US
06:00am, Tuesday, 29'th Jun 2021
VANCOUVER, BC / ACCESSWIRE / June 29, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), a psychedelic drug development company, is pleased to announce t
NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
06:00am, Monday, 14'th Jun 2021
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind" or the "Company"), an integrated drug development and wellne
NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products
06:00am, Thursday, 10'th Jun 2021
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FSE: 6UF) ("NeonMind"), is pleased to announce that Vitasave has agreed to carry a
